Patient Guide: A Study of ACP-196 (Acalabrutinib) in Subjects With Relapsed/Refractory CLL and Intolerant of Ibrutinib Therapy

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 23 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT02717611
Status: ACTIVE_NOT_RECRUITING
Condition: Chronic Lymphocytic Leukemia
Phase: PHASE2

Where You Can Participate

This study is available at 23 locations across the country.

Top locations include:
  • • Tucson, Arizona
  • • Concord, California
  • • La Jolla, California
  • • And 20 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of ACP-196 (Acalabrutinib) in Subjects With Relapsed/Refractory CLL and Intolerant of Ibrutinib Therapy - Join Clinical Trial NCTNCT02717611

How to Join This Clinical Trial - NCTNCT02717611

Learn how to participate in this PHASE2 trial studying an investigational therapy for Chronic Lymphocytic Leukemia. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Chronic Lymphocytic Leukemia. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Chronic Lymphocytic Leukemia
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT02717611 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 23 locations. Find a study site near you:

Clinical Research Site

Tucson, Arizona 85704 - United States

Status: Contact for availability

Clinical Research Site

Concord, California 94520 - United States

Status: Contact for availability

Clinical Research Site

La Jolla, California 92093 - United States

Status: Contact for availability

Clinical Research Site

Palo Alto, California 94304 - United States

Status: Contact for availability

Clinical Research Site

Washington, District of Columbia 20007 - United States

Status: Contact for availability

Clinical Research Site

Chicago, Illinois 60611 - United States

Status: Contact for availability

Clinical Research Site

Lake Success, New York 11042 - United States

Status: Contact for availability

Clinical Research Site

New York, New York 10021 - United States

Status: Contact for availability

Clinical Research Site

Columbus, Ohio 43210 - United States

Status: Contact for availability

Clinical Research Site

Nashville, Tennessee 37203 - United States

Status: Contact for availability

And 13 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Chronic Lymphocytic Leukemia:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships